Sanofi-Aventis Australia
Administration route: 
Intramuscular injection, Subcutaneous injection
Vaccine group: 
Yellow fever vaccine available in Australia

Registered for use in people aged ≥9 months.

Live attenuated yellow fever vaccine

Lyophilised powder in a monodose vial with a pre-filled diluent syringe.

Each 0.5 mL reconstituted dose contains:

  • ≥1000 IU of yellow fever virus (17D strain)
  • 16.0 mg lactose
  • 8.0 mg sorbitol
  • 833 µg L-histidine hydrochloride

May contain traces of egg proteins.

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018


international units